Podchaser Logo
Podchaser Logo
Charts
Testing, testing, testing is the challenge not swiftly answered & What is to be done? @HenryIMiller @PacificResearch

Testing, testing, testing is the challenge not swiftly answered & What is to be done? @HenryIMiller @PacificResearch

Released Saturday, 18th April 2020
Good episode? Give it some love!
Testing, testing, testing is the challenge not swiftly answered & What is to be done? @HenryIMiller @PacificResearch

Testing, testing, testing is the challenge not swiftly answered & What is to be done? @HenryIMiller @PacificResearch

Testing, testing, testing is the challenge not swiftly answered & What is to be done? @HenryIMiller @PacificResearch

Testing, testing, testing is the challenge not swiftly answered & What is to be done? @HenryIMiller @PacificResearch

Saturday, 18th April 2020
Good episode? Give it some love!
Rate Episode
List
Photo: The US CDC's 2019-nCoV Laboratory Test Kit
http://JohnBatchelorShow.com/contact
http://JohnBatchelorShow.com/schedules
Twitter: @BatchelorShow

Testing, testing, testing is the challenge not swiftly answered & What is to be done? @HenryIMiller @PacificResearch


  • Johnson & Johnson aims to produce 600 million to 900 million doses of its potential coronavirus vaccine by April 2021 if human trials set to begin in September go as planned, J&J executives said Tuesday.

https://www.cnbc.com/2020/04/14/jj-can-produce-up-to-900-million-coronavirus-vaccine-doses-by-april-2021-if-trials-go-well.html
Show More